addS

Showing posts with label koncept analysis. Show all posts
Showing posts with label koncept analysis. Show all posts

Thursday 18 July 2013

Latest Release On Construction Market Growth in Lithuania Key Trends and Opportunities to 2017


This report provides detailed market analysis, information and insights into the Lithuanian construction market, including:

  • The Lithuanian construction market’s growth prospects by sector, project type and type of construction activity
  • Analysis of equipment, material and service costs across each project type within Lithuania
  • Critical insight into the impact of industry trends and issues and the risks and opportunities they present to participants in the Lithuanian construction market
  • Assessment of the competitive forces facing the construction industry in Lithuania and profiles of the leading players
  • Data highlights of the largest construction projects in Lithuania


Scope

This report provides a comprehensive analysis of the construction industry in Lithuania:

  • Historical (2008-2012) and forecast (2013-2017) valuations of the construction market in Lithuania using the construction output and value-add methods
  • Segmentation by sector (commercial, industrial, infrastructure, institutional and residential) and by project type
  • Breakdown of values within each project type, by type of activity (new construction, repair and maintenance, refurbishment and demolition) and by type of cost (materials, equipment and services)
  • Analysis of key construction industry issues, including regulation, cost management, funding and pricing
  • Assessment of the competitive environment using Porter’s Five Forces
  • Detailed profiles of the leading construction companies in Lithuania


Executive summary

The Lithuanian construction industry recorded a CAGR of -15.50% during the review period (2008−2012). The housing market contracted in 2009 as interest rates began to rise and banks tightened their lending conditions. Deflation in the property sector was one of the key factors in the decline in domestic demand and contributed to the country’s economic contraction of 15% in 2009. Infrastructure investment supported the construction industry during the financial crisis, recording the lowest decline of all construction markets during the review period at a CAGR of -6.43%. Timetric expects the Lithuanian construction industry to record a CAGR of 3.52% over the forecast period (2012−2017).


Reasons to buy

  • Identify and evaluate market opportunities using our standardized valuation and forecasting methodologies
  • Assess market growth potential at a micro-level via 600+ time series data forecasts
  • Understand the latest industry and market trends
  • Formulate and validate business strategies by leveraging our critical and actionable insight
  • Assess business risks, including cost, regulatory and competitive pressures
  • Evaluate competitive risk and success factors


Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Friday 21 June 2013

New Study On Breast Cancer Market Report: 2013 Edition

Riding on the back of evolving technological environment, the global healthcare and pharmaceutical industry is now surmounting new acmes. The growth of the respective sector is further filliped by the increasing number of health related issues surfacing on account of changing lifestyle and incessantly evolving surroundings. 



To cater to the necessity of better healthcare options and the unmet needs within the some of the underlying segments, related companies are coming up with novel and improved diagnostic technologies and treatment therapies, especially in the field of breast cancer treatment.

‘Cancer’ is the result of any mutation or abnormal changes in the genes which are responsible for regulating the growth of cells and keeping them healthy. The tumor formed due to cancer can be either ‘benign’ (not dangerous) or ‘malignant’ (potentially dangerous). ‘Breast cancer’ is a malignant tumor that has developed from cells in the breast. Typically breast cancer either begins in the cells of the lobules (milk-producing glands), or the ducts (the passages that drain milk from the lobules to the nipple).
The stages of breast cancer are crucial as they only determine the type of treatment method and the extent to which the disease can be cured. 

On the diagnosis front, mammography is believed to diagnose 85% to 90% of breast cancers in women over 50, and is capable of discovering a lesion one to four years before a lump can be felt. In case of patients with dense breast tissue, breast implants or patients who are breastfeeding, mammography cannot produce clear images; therefore, in such cases, ultrasound or MRI is recommended. Biopsy is used for the diagnosis of breast cancer once a lesion is detected in screening. For treatment of breast cancer, the first method to be used is surgical, followed by hormone therapy, chemo therapy or radiation therapy.

After lung cancer, breast cancer is the 2nd most prevalent type of cancer and 5th most common cause of cancer deaths on global scale. Over one million new cases of breast cancer are diagnosed every year world over.




The present report offers a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions like the US, India and Brazil including the revenue build of two major drugs in the coming years. Furthermore, market dynamics such as the industry trends and development, the underlying growth drivers and major issues faced by the industry are elicited. 

On the contention front, the market is personified by the intense competition in terms of research and development of novel therapeutic molecules, diagnostics technology application and pricing of the product. The leading players operating in the industry include Hologic, J&J and Siemens AG which are also profiled in this report.


About Us

MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are especially designed to save time and money of our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948